Charles River Labs ( (CRL) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Charles River Laboratories’ stock has been affected by the recent resignation of CFO Flavia Pease, which has introduced uncertainty amid tough macroeconomic conditions. Although the company has appointed Michael Knell as interim CFO and reaffirmed its 2025 guidance, negative insider sentiment and bearish technical analysis have led to cautious analyst ratings, impacting the stock’s performance.
More about Charles River Labs
YTD Price Performance: -16.64%
Average Trading Volume: 876,372
Technical Sentiment Signal: Sell
Current Market Cap: $7.49B
For further insights into CRL stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.